# Exact Sciences

launched Cancerguard, which the company calls the first-of-its-kind multi-cancer early detection blood test.

Source: https://en.bioecon.ru/companies/exact-sciences/
Updated: 2026-07-20

- Country: United States
- Ticker: EXAS

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $2.80 billion (total historical funding) | https://trial.medpath.com/news/exact-sciences-launches-cancerguard-multi-cancer-blood-test-for-early-detection |
| Capacity | approximately 7 million tests per year (combined for Cologuard, Cologuard Plus, and Cancerguard) | https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm |
| Certification | CLIA-certified and CAP-accredited laboratories | https://lustgarten.org/from-cancerseek-to-cancerguard-how-early-research-sparked-a-new-era-in-cancer-detection/, https://www.exactsciences.com/cancer-testing/cancerguard-mced-providers, https://www.exactsciences.com/cancer-testing/cancerguard-mced-providers/resources |
| Regulatory approval | not FDA cleared or approved (offered as a Laboratory Developed Test) | https://lustgarten.org/from-cancerseek-to-cancerguard-how-early-research-sparked-a-new-era-in-cancer-detection/, https://www.cancerguard.com/, https://www.exactsciences.com/-/media/B747982B407149ADAFF98AEDF3B82E97.pdf, https://www.exactsciences.com/cancer-testing/cancerguard-mced-providers, https://www.exactsciences.com/cancer-testing/cancerguard-mced-providers/resources |
| Production site | Madison, Wisconsin | https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/exas-20251231.htm |
| Headcount | more than 7,000 employees | https://trial.medpath.com/news/exact-sciences-launches-cancerguard-multi-cancer-blood-test-for-early-detection |
| Revenue | expected $3.1 billion for 2025 | https://trial.medpath.com/news/exact-sciences-launches-cancerguard-multi-cancer-blood-test-for-early-detection |

Independent sources: cancerguard.com, lustgarten.org, sec.gov, trial.medpath.com

## Technologies

- [Multi-cancer early detection (MCED)](https://en.bioecon.ru/technology/multi-cancer-early-detection/)